Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis

In this study, a panel of 39 primary malignant fibrous histiocytomas (MFH) of high malignancy grade were characterised for chromosomal alterations. The results were then evaluated in relation to the survival and the occurrence of recurrent disease during follow-up for an average period of 63 months....

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, W-H, Åhlén, J, Lui, W-O, Brosjö, O, Pang, S-T, von Rosen, A, Auer, G, Larsson, O, Larsson, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376905/
https://www.ncbi.nlm.nih.gov/pubmed/12915885
http://dx.doi.org/10.1038/sj.bjc.6601069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376905/
https://www.ncbi.nlm.nih.gov/pubmed/12915885
http://dx.doi.org/10.1038/sj.bjc.6601069

Ejemplares similares